Animal Health Market Developments by 2031
The animal health market is projected to reach US$ 126,500.20 million by 2031 from US$ 87,547.03 million in 2022; it is estimated to register a CAGR of 6.2% from 2022 to 2031.
Preventing animal disease and monitoring animal food supplies are vital to ensure safety of food supply. Breeding of healthy livestock guarantees a safe supply of food and keep selling prices stable. Zoonotic diseases can adversely affect public health, international trade, and the stability of the agricultural sector, resulting in a loss of millions of dollars owing to livestock trade halts, animal slaughters, and subsequent disease elimination efforts. In November 2017, Porcine reproductive and respiratory syndrome virus (PRRSV) that causes stillborn piglets costed the US farmers US$ 600 million. Disease free and healthy animals are therefore likely to result in safer food supplies, higher farm productivity, reduced environmental impacts, reduced use of antibiotics.
Factors such as increasing incidences of zoonotic diseases, rise in the demand for proteinaceous food, and initiatives by governments and animal welfare associations are expected to propel the growth of the animal health market during the forecast period. However, the use of counterfeit medicines, and high complexity and cost of animal drug development and approval processes are likely to pose a negative impact on the animal health market growth.
The animal health market is segmented based on product, animal type, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.
Strategic Insights
Market Insights
Increased Adoption of Pets for Companionship
The adoption of pets is a significant animal healthcare market trend. More than 67% of American households own pets, totaling almost 400 million pets, including dogs, cats, horses, birds, and fish. As per American Society for the Prevention of Cruelty to Animals, ~6.5 million companion animals enter the countrywide animal shelters every year. The number of dogs and cats entering these shelters yearly has declined from ~7.2 million in 2011. This decline can be moderately explained by an increase in the percentage of animals adopted. As per the European Pet Food Industry Federation (FEDIAF), cats remain the most popular pets in European households with a stable population of 74.4 million in the region. Also, the popularity of dogs is growing as there were 66.4 million pet dogs in the EU (84.9 million in Europe and Russia) in 2017, compared to 63.7 million (82.2 million) in 2016.
Americans spent over US$ 75.5 billion on their pets in 2016, with an average total household expenditure of US$ 892 on pet food, veterinary services, supplies, and other services. Pets improve their owners’ overall health and well-being, and may help them live longer. Research shows dog owners have a 36% lower risk of dying from cardiovascular disease and an 11% lower risk of a heart attack. Hence, the trend toward the adoption of pets is likely to drive the market growth in the study period.
Increase in R&D Activities
Over the last two decades, the cost and time of developing an animal health product have both increased by >100% and six years, respectively. According to the Animal Health Institute’s Research and Development Survey, animal health companies spent US$ 663 million in 2006 in the R&D pertaining to new potential products as well as in the research for maintaining the long life of offered products. This constitutes a 7% increase over the spending reported in 2005. Innovative research accounts for 86% of total R&D spending, while the remaining 14% was occupied by the research required to ensure prolonged performance of existing products.
Investments by significant players are further likely to augment the market growth. For instance, Zoetis is focused on continuous innovation to develop animal health solutions meeting the needs of buyers. R&D is at the center of the company’s efforts to provide innovation outcomes that anticipate the future needs of veterinarians and livestock producers in their local markets. On January 30, 2021, Zoetis and Colorado State University signed an agreement to establish the Zoetis Incubator Research Lab and begin a research collaboration focused on exploring the livestock immune system to target new immunotherapies.
Product-Based Insights
Based on product, the animal health market is segmented into prescription and non-prescription. The prescription segment held a larger share of the market in 2022. The non-prescription segment is estimated to register a higher CAGR of 7.0% in the market during the forecast period. The prescription segment is further sub-segmented into vaccines, pharmaceuticals, feed additives, and diagnostics. The non-prescription segmented is further categorized into parasiticides, grooming products, and nutrition/supplements.
Animal Type-Based insight
Based on animal type, the animal health market is segmented into production animal and companion animal. The production animal segment held a larger share of the market in 2022. The companion animal segment is estimated to register a higher CAGR of 6.8% in the market during the forecast period.
Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global animal health market. A few of the recent key product developments are listed below:
In February 2021, Vetoquinol SA announced the acquisition of Profender and Drontal product families from Elanco Animal Health. It will also acquire intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
In January 2021, Nutreco N.V. announced investment in a Dutch company Kingfish Zeeland. The company aims to bring supplies of yellowtail kingfish to the US and European markets. The distribution will be done through a proprietary recirculating aquaculture system.
In March 2021, Bayer AG announced the launch of Care4Pigs initiative; this was launched in collaboration with the Farm Animal Welfare Education Centre (FAWEC) and the Korean Association of Swine Veterinarians (KASV). Under the collaboration, EUR 10,000 were granted to support innovation aimed at enhancing swine well-being.
In February 2021, Zoetis received FDA approval for Simparica Trio, a new combination parasite preventative for dogs. It is a first monthly chewable tablet launched in the US, which provides all-in-one protection from heartworm disease, ticks, and fleas, roundworms, and hookworms in dogs.
Company Profiles
- Merck & Co., Inc
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Cargill, Incorporated
- Zoetis Inc.
- Bayer AG
- Vetoquinol SA
- Nutreco N.V
- Virbac
- Elanco
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, and Animal Type
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Developing a drug for animals is much complicated and is a bit expensive. The stringent government regulations for drug approvals are the biggest hurdles in the animal health industry. The drug development process can take up to 5–7 years and cost more than US$ 10 million before entering the stage of approval. In addition, animal medicines remain heavily regulated and are subjected to strict laws that protect animals and humans, as well as the environment. Thus, drug development for animals is quite costlier, and sometimes it may become a restraint for the animal health market.
The growth of animal health market is driven by some key driving factors such as increasing incidences of zoonotic diseases, rise in demand for proteinaceous food, and initiatives by governments and animal welfare associations. However the use of counterfeit medicines, and high complexity and cost of animal drug development and approval processes are likely to restraint the market growth during the forecast period.
Similar to human animals are also affected by various diseases, which result in behavioral changes, uneasy conditions, and less production, among others. Several types of diseases can adversely affect animal health, and the diseases may include zoonotic diseases, transboundary diseases, insect-borne diseases, and diseases of production and hygiene, among others. On the other hand, animals assist in building economies through various businesses. For instance, production or livestock animals guarantee a safe supply of food and keep selling prices stable, which in return helps in earning a good income. Therefore, it is essential to maintain good animal health. Animals can be kept healthy by taking measures for their health. Animal owners should regularly take their animals to veterans to diagnose problems related to their health. The animal should be regularly given vaccines to prevent diseases. Thus, such measures assist in marinating good animal health.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Animal Health Market– By Product
1.3.2 Global Animal Health Market– By Animal Type
1.3.3 Global Animal Health Market– By Geography
2. Animal Health Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Animal Health Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America
4.2.2 Europe
4.2.3 Asia Pacific
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion
5. Global Animal Health Market – Key Market Dynamics
5.1 Key Drivers
5.1.1 Increasing Incidences Of Zoonotic Diseases
5.1.2 Rise in Demand for Proteinaceous Food
5.1.3 Initiatives by Governments and Animal Welfare Associations
5.2 Key Restraints
5.2.1 Use of Counterfeit Medicines
5.2.2 High Complexity and Cost of Animal Drug Development and Approval Processes
5.3 Opportunities
5.3.1 Increase in R&D Activities
5.4 Trends
5.4.1 Increased Adoption Of Pets By People For Companionship
5.4.2 Public Private Partnership for Animal Health Regulation
5.5 Impact Analysis
6. Animal Health Market– Global Analysis
6.1 Global Animal Health Market Revenue Forecast And Analysis
6.2 Global Animal Health Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Animal Health Market Analysis – By Product
7.1 Overview
7.2 Animal Health Market Share, by Product, 2019 and 2027 (%)
7.3 Prescription
7.3.1 Overview
7.3.2 Prescription: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.3.3 Feed Additives
7.3.3.1 Overview
7.3.3.2 Feed Additives: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.3.4 Pharmaceutical
7.3.4.1 Overview
7.3.4.2 Pharmaceutical: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.3.5 Vaccines
7.3.5.1 Overview
7.3.5.2 Vaccines: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.3.6 Diagnostics
7.3.6.1 Overview
7.3.6.2 Diagnostics: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Non-Prescription
7.4.1 Overview
7.4.2 Non-prescription: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Nutrition Supplements
7.4.3.1 Overview
7.4.3.2 Nutrition Supplements: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Parasiticides
7.4.4.1 Overview
7.4.4.2 Parasiticides: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
7.4.5 Grooming Products
7.4.5.1 Overview
7.4.5.2 Grooming Products: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
8. Animal Health Market Analysis – By Animal Type
8.1 Overview
8.2 Animal Health Market Share, by Animal Type, 2019 and 2027 (%)
8.3 Production Animal
8.3.1 Overview
8.3.2 Production Animal: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
8.4 Companion Animal
8.4.1 Overview
8.4.2 Companion Animal: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
9. Animal Health Market – Geographic Analysis
9.1 North America: Animal Health Market
9.1.1 Overview
9.1.2 North America: Animal Health Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 North America Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 North America Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.4 North America Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Animal Health Market, by Country, 2019 & 2027 (%)
9.1.6 US: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 US Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 US Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 Canada Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Canada Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 Mexico Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Mexico Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.2 Europe: Animal Health Market
9.2.1 Overview
9.2.2 Europe: Animal Health Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.3.1 Europe Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.3.2 Europe Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Animal Health Market, by Country, 2019 & 2027 (%)
9.2.6 Spain: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Spain: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Spain Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.6.2.1 Spain Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.6.2.2 Spain Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Spain Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.2.7 Germany: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 Germany: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 Germany Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.7.2.1 Germany Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.7.2.2 Germany Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.7.3 Germany Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.2.8 France: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.8.2.1 France Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.8.2.2 France Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.8.3 France Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.2.9 United Kingdom: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 United Kingdom: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 United Kingdom Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.9.2.1 United Kingdom Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.9.2.2 United Kingdom Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.9.3 United Kingdom Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.2.10 Italy: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.2.10.2.1 Italy Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.10.2.2 Italy Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Italy Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.3 Asia Pacific: Animal Health Market
9.3.1 Overview
9.3.2 Asia Pacific: Animal Health Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.3.1 Asia Pacific Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.3.2 Asia Pacific Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.4 Asia Pacific Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.3.5 Asia Pacific: Animal Health Market, by Country, 2019 & 2027 (%)
9.3.6 China: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.6.2.1 China Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.6.2.2 China Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.6.3 China Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.3.7 India: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 India: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 India Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.7.2.1 India Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.7.2.2 India Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.7.3 India Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.3.8 Japan: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 Japan: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 Japan Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.8.2.1 Japan Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.8.2.2 Japan Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.8.3 Japan Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.3.9 Australia: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 Australia: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 Australia Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.9.2.1 Australia Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.9.2.2 Australia Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.9.3 Australia Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.3.10 South Korea: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 South Korea: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 South Korea Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.3.10.2.1 South Korea Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.10.2.2 South Korea Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.3.10.3 South Korea Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.4 Middle East and Africa: Animal Health Market
9.4.1 Overview
9.4.2 Middle East and Africa: Animal Health Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East and Africa Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.3.1 Middle East and Africa Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.3.2 Middle East and Africa Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East and Africa: Animal Health Market, by Country, 2019 & 2027 (%)
9.4.6 South Africa: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 South Africa: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 South Africa Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.6.2.1 South Africa Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.6.2.2 South Africa Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.6.3 South Africa Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.4.7 Saudi Arabia: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 Saudi Arabia: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 Saudi Arabia Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.7.2.1 Saudi Arabia Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.7.2.2 Saudi Arabia Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.7.3 Saudi Arabia Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.4.8 UAE: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.1 UAE: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 UAE Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.4.8.2.1 UAE Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.8.2.2 UAE Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.4.8.3 UAE Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Animal Health Market
9.5.1 Overview
9.5.2 South and Central America: Animal Health Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.3.1 South and Central America Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.5.3.2 South and Central America a Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Animal Health Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.6.2.1 Brazil Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.5.6.2.2 Brazil Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.5.7.2.1 Argentina Prescription, by Type – Revenue and Forecast to 2027 (USD Million)
9.5.7.2.2 Argentina Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic On Global Animal Health Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Animal Health Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Animal Health Market, 2017-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Merck & Co., Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Boehringer Ingelheim International GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ceva Santé Animale
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cargill, Incorporated
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Zoetis Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bayer AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Vetoquinol SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nutreco N.V
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Virbac
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Elanco
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Word Index
LIST OF TABLES
Table 1. North America Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 5. US Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. US Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Spain Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 22. Spain Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 23. Spain Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 24. Spain Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 25. Germany Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 26. Germany Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Germany Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Germany Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 29. France Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 30. France Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 31. France Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 32. France Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 33. United Kingdom Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 34. United Kingdom Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. United Kingdom Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. United Kingdom Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 41. Asia Pacific Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 42. Asia Pacific Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Asia Pacific Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Asia Pacific Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 45. China Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 46. China Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 47. China Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 48. China Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 49. India Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 50. India Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 51. India Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 52. India Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 53. Japan Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 54. Japan Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 55. Japan Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 56. Japan Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 57. Australia Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 58. Australia Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 59. Australia Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 60. Australia Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 61. South Korea Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 62. South Korea Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 63. South Korea Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 65. Middle East and Africa Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 66. Middle East and Africa Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 67. Middle East and Africa Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 68. Middle East and Africa Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 69. South Africa Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 70. South Africa Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 71. South Africa Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 72. South Africa Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 73. Saudi Arabia Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 74. Saudi Arabia Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 75. Saudi Arabia Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 76. Saudi Arabia Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 77. UAE Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 78. UAE Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 79. UAE Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 80. UAE Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 81. South and Central America Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 82. South and Central America Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 83. South and Central America Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 84. South and Central America Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 85. Brazil Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 86. Brazil Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 87. Brazil Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 88. Brazil Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 89. Argentina Animal Health Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 90. Argentina Prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 91. Argentina Non-prescription Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 92. Argentina Animal Health Market, by Animal Type – Revenue and Forecast to 2027 (USD Million)
Table 93. Recent Inorganic Growth Strategies In The Animal Health Market
Table 94. Recent Organic Growth Strategies In The Animal Health Market
Table 95. List of Abbreviation
LIST OF FIGURES
Figure 1. Animal Health Market Segmentation
Figure 2. Animal Health Market, By Region
Figure 3. Global Animal Health Market Overview
Figure 4. Prescription Segment Held Largest Share Of Product Segment In Animal Health Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Animal Health Market, By Geography (US$ Million)
Figure 7. Global Animal Health Market- Leading Country Markets (US$ Million)
Figure 8. Global Animal Health Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Expert Opinion
Figure 15. Animal Health Market Impact Analysis Of Drivers and Restraints
Figure 16. Global Animal Health Market– Revenue Forecast and Analysis – 2019- 2027
Figure 17. Global Animal Health Market– By Geography Forecast And Analysis – 2019- 2027
Figure 18. Market Positioning Of Key Players In Global Animal Health Market
Figure 19. Animal Health Market Share, by Product, 2019 and 2027 (%)
Figure 20. Prescription: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 21. Feed Additives: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 22. Pharmaceutical: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 23. Vaccines: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 24. Diagnostics: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 25. Non-prescription: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 26. Nutrition Supplements: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 27. Parasiticides: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 28. Grooming Products: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 29. Animal Health Market Share, by Animal Type, 2019 and 2027 (%)
Figure 30. Production Animal: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 31. Companion Animal: Animal Health Market– Revenue and Forecast to 2027 (US$ Million)
Figure 32. North America: Animal Health Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. North America Animal Health Market Revenue and Forecast to 2027 (USD Million)
Figure 34. North America: Animal Health Market, by Country, 2019 & 2027 (%)
Figure 35. US: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Canada: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Mexico: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Europe: Animal Health Market, by Key Country – Revenue (2019) (USD Million)
Figure 39. Europe Animal Health Market Revenue and Forecast to 2027 (USD Million)
Figure 40. Europe: Animal Health Market, by Country, 2019 & 2027 (%)
Figure 41. Spain: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. Germany: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. France: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. United Kingdom: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Italy: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Asia Pacific: Animal Health Market, by Key Country – Revenue (2019) (USD Million)
Figure 47. Asia Pacific Animal Health Market Revenue and Forecast to 2027 (USD Million)
Figure 48. Asia Pacific: Animal Health Market, by Country, 2019 & 2027 (%)
Figure 49. China: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. India: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Japan: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. Australia: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. South Korea: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Middle East and Africa: Animal Health Market, by Key Country – Revenue (2019) (USD Million)
Figure 55. Middle East and Africa Animal Health Market Revenue and Forecast to 2027 (USD Million)
Figure 56. Middle East and Africa: Animal Health Market, by Country, 2019 & 2027 (%)
Figure 57. South Africa: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Saudi Arabia: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. South and Central America: Animal Health Market, by Key Country – Revenue (2019) (USD Million)
Figure 61. South and Central America Animal Health Market Revenue and Forecast to 2027 (USD Million)
Figure 62. South and Central America: Animal Health Market, by Country, 2019 & 2027 (%)
Figure 63. Brazil: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. Argentina: Animal Health Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Impact of COVID-19 Pandemic In North American Country Markets
Figure 66. Impact of COVID-19 Pandemic in European Country Markets
Figure 67. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 68. Impact of COVID-19 Pandemic in North American Country Market
Figure 69. Growth Strategies in the Animal Health Market, 2017-2020
The List of Companies - Animal Health Market
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Cargill, Incorporated
- Zoetis Inc.
- Bayer AG
- Vetoquinol SA
- Nutreco N.V
- Virbac
- Elanco
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For